Federal Government Relations Senior Advisor Bill Thomas Noted on Whereabouts in the National Journal
"Thomas may no longer be spending time in front of TV cameras," explained the article, "but the former Republican chairman of the House Ways and Means Committee isn't gone from Washington. Indeed, the bold and sometimes brash Thomas was a leading voice on health care policy during his time on the Hill, and he continues to make time to answer the calls he still gets from former colleagues. He was not inclined to continue his high-profile presence during the health care reform debate last winter, even though he is known as a GOP thought leader on the issue."
As explained in the article, "Thomas represented California in Congress from1979 to 2007. He now splits his time between the American Enterprise Institute, where he consults on tax, trade, and health care policy, and law firm Buchanan Ingersoll & Rooney. He is also vice chairman of the Financial Crisis inquiry Commission that President Obama and Congress created last year to study the causes of the nation's financial and economic meltdown."
Related Services & Industries
- AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT
- ANTITRUST & TRADE REGULATION
- APPELLATE
- ATTORNEY UPDATE
- AUTONOMOUS & CONNECTED VEHICLES
- BANKRUPTCY & CREDITORS' RIGHTS
- BLOCKCHAIN & DIGITAL ASSETS
- BUCHANAN IP GUEST ASSOCIATE PROGRAM
- BUCHANAN LABS
- BUSINESS TAX
- CANNABIS
- CLASS ACTIONS
- COAL
- COMBINED HEAT & POWER (CHP)
- COMMERCIAL FINANCE
- CONSTRUCTION
- CONSUMER DEFENSE
- CONSUMER PRODUCTS
- CONTACT INFORMATION
- CONVERGENCE: M&A INSIGHTS IN HEALTHCARE
- COPYRIGHT
- CORONAVIRUS (COVID-19)
- CORPORATE
- CORPORATE COMPLIANCE
- CORPORATE TRANSPARENCY ACT
- CRIMINAL DEFENSE & GOVERNMENT ENFORCEMENT
- CYBERSECURITY & DATA PRIVACY
- DIVERSITY & INCLUSION
- DRUG TARGET ANALYSIS
- E-DISCOVERY
- EDUCATION
- EMERGING COMPANIES
- EMPLOYEE BENEFITS & ERISA
- EMPLOYMENT LITIGATION
- ENERGY
- ENTERTAINMENT, MEDIA & SPORTS
- ENVIRONMENTAL
- ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)
- ESTATES & TRUSTS
- EXECUTIVE COMPENSATION
- FAMILY OFFICE
- FDA & BIOTECHNOLOGY
- FINANCE
- FRANCHISE & DISTRIBUTION
- GOVERNMENT RELATIONS & PUBLIC POLICY
- HEALTHCARE
- HEALTHCARE ADMINISTRATIVE & JUDICIAL PROCEEDINGS
- HEALTHCARE INFORMATION SECURITY & PRIVACY
- HEALTHCARE LITIGATION
- HEALTHCARE REGULATORY & COMPLIANCE
- HEALTHCARE TRANSACTIONS
- HOSPITALITY
- HR & EMPLOYEE RELATIONS ISSUES
- IMMIGRATION
- INNOVATIVE HEALTHCARE DELIVERY & PAYMENT
- INSIDER INSIGHTS: 100 DAYS OF BIDEN
- INSURANCE & REINSURANCE
- INTELLECTUAL PROPERTY
- INTERNAL INVESTIGATIONS
- INTERNATIONAL SERVICES
- INTERNATIONAL TAX
- INTERNATIONAL TRADE & NATIONAL SECURITY
- IP LITIGATION
- LABOR & EMPLOYMENT
- LIFE SCIENCES
- LIFE SCIENCES LITIGATION
- LITIGATION
- MANUFACTURING
- MARITIME & ADMIRALTY
- MATRIMONIAL & FAMILY LAW
- MERGERS & ACQUISITIONS
- NATIONAL SECURITY EXPORT CONTROLS AND ECONOMIC SANCTIONS
- NONPROFIT ORGANIZATIONS
- OIL & GAS
- OPPORTUNITY ZONES
- PASS-THROUGH ENTITIES
- PATENT COUNSELING & STRATEGIC ADVICE
- PATENT OFFICE LITIGATION
- PATENT PROCUREMENT
- POST-ACUTE & LONG-TERM CARE
- POWER GENERATION & UTILITY
- PRIVATE EQUITY AND VENTURE CAPITAL
- PRODUCT LIABILITY
- PUBLIC FINANCE
- PUBLIC PROCUREMENT & BID PROTESTS
- REAL ESTATE
- REAL ESTATE FINANCE
- REAL ESTATE TRANSACTIONS
- REIMBURSEMENT & MANAGED CARE
- RENEWABLES AND ALTERNATIVE ENERGY
- SECURITIES & SEC
- SECURITY ALARM
- SPORTS
- STATE & LOCAL TAX
- TAX
- TAX CONTROVERSY
- TECHNOLOGY, LICENSING AND COMMERCIAL CONTRACTS
- TITLE IX
- TRADE REMEDIES
- TRADE SECRETS & RESTRICTIVE COVENANTS